Page last updated: 2024-10-24

transepithelial water transport

Definition

Target type: biologicalprocess

The directed movement of water (H2O) from one side of an epithelium to the other. [GOC:yaf]

Transepithelial water transport is a crucial physiological process that involves the movement of water across epithelial cell layers, which line the surfaces of organs and cavities within the body. This process is essential for maintaining fluid balance, regulating blood pressure, and facilitating nutrient absorption. Here's a detailed breakdown of the process:

**1. Water Movement Across the Cell Membrane:**

* Water primarily moves across cell membranes through osmosis, a passive process driven by differences in water potential.
* Water potential is influenced by solute concentration, pressure, and gravitational forces.
* Water moves from areas of high water potential (low solute concentration) to areas of low water potential (high solute concentration) to achieve equilibrium.

**2. Aquaporins: The Water Channels:**

* Aquaporins are transmembrane proteins that form selective water channels in cell membranes, facilitating rapid water transport.
* These channels are highly regulated, allowing for precise control of water flow.

**3. Transcellular and Paracellular Pathways:**

* Water can move across epithelial cells via two main pathways:
* **Transcellular pathway:** Water moves through the cell, passing through both the apical (facing the lumen) and basolateral (facing the blood) membranes.
* **Paracellular pathway:** Water moves between adjacent cells through tight junctions, which are protein complexes that regulate intercellular permeability.

**4. Driving Forces for Water Transport:**

* **Osmotic pressure gradients:** The concentration difference of solutes between the lumen and the blood creates an osmotic pressure gradient, driving water movement.
* **Hydrostatic pressure gradients:** Pressure differences across the epithelium, such as blood pressure in capillaries, can also influence water transport.

**5. Regulation of Transepithelial Water Transport:**

* **Hormonal control:** Hormones like antidiuretic hormone (ADH) and aldosterone play crucial roles in regulating water reabsorption in the kidneys.
* **Neural regulation:** The nervous system can influence water transport by controlling the activity of aquaporins and other membrane transport proteins.

**6. Examples of Transepithelial Water Transport:**

* **Kidney:** Reabsorption of water from the filtrate in the nephron, contributing to urine formation.
* **Intestine:** Absorption of water from ingested food, facilitating nutrient digestion and absorption.
* **Lungs:** Transport of water vapor from the blood into the alveoli for gas exchange.
* **Salivary glands:** Secretion of saliva, containing water and electrolytes.
* **Sweat glands:** Secretion of sweat, primarily composed of water, for thermoregulation.

Transepithelial water transport is a complex process that involves intricate interplay between membrane transport, cell signaling, and hormonal regulation. It is essential for maintaining fluid balance, regulating blood pressure, and supporting various physiological processes within the body.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Aquaporin-1An aquaporin-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P29972]Homo sapiens (human)
Sodium/glucose cotransporter 1A sodium/glucose cotransporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P13866]Homo sapiens (human)
Cystic fibrosis transmembrane conductance regulatorA cystic fibrosis transmembrane conductance regulator that is encoded in the genome of human. [PRO:CNA, UniProtKB:P13569]Homo sapiens (human)

Compounds (29)

CompoundDefinitionClassesRoles
glyburideglyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
monochlorobenzenes;
N-sulfonylurea
anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
phloretindihydrochalconesantineoplastic agent;
plant metabolite
phlorhizinaryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative
antioxidant;
plant metabolite
methyl anthranilatemethyl anthranilate : A benzoate ester that is the methyl ester of anthranilic acid.benzoate esterflavouring agent;
metabolite
telmisartantelmisartan : A member of the class of benzimidazoles used widely in the treatment of hypertension.

Telmisartan: A biphenyl compound and benzimidazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION.
benzimidazoles;
biphenyls;
carboxybiphenyl
angiotensin receptor antagonist;
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
environmental contaminant;
xenobiotic
vexibinolsophoraflavanone G : A tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2' as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8'.

vexibinol: flavanol from Sophora; structure in first source; RN given refers to (S-(R*,S*))-isomer
(2S)-flavan-4-one;
4'-hydroxyflavanones;
tetrahydroxyflavanone
antimalarial;
antimicrobial agent;
antioxidant;
plant metabolite
tadalafilbenzodioxoles;
pyrazinopyridoindole
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine
2',4',6'-Trihydroxydihydrochalconechalcones
3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone: a cystic fibrosis transmembrane conductance regulator inhibitor; structure in first source
uccf-029organic heterotricyclic compound;
organooxygen compound
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
apigeninChamomile: Common name for several daisy-like plants (MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM) native to Europe and Western Asia, now naturalized in the United States and Australia.trihydroxyflavoneantineoplastic agent;
metabolite
rutinHydroxyethylrutoside: Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders.disaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone
antioxidant;
metabolite
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
cgp 71683 anaphthalenes;
sulfonic acid derivative
2',4',6'-trihydroxychalconepinocembrin chalcone : A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2', 4' and 6' respectively.

pinocembrin chalcone: isolated from Helichrysum trilineatum; structure in first source
chalconesantifungal agent;
plant metabolite
sergliflozin etabonatesergliflozin: a hypoglycemic agent that inhibits SGLT2 sodium-glucose transporter; structure in first sourceglycoside
remogliflozin etabonateremogliflozin etabonate: orally administered hypoglycemic agent; structure in first sourceglycoside
dapagliflozinaromatic ether;
C-glycosyl compound;
monochlorobenzenes
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
ipragliflozinglycoside
empagliflozinaromatic ether;
C-glycosyl compound;
monochlorobenzenes;
tetrahydrofuryl ether
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitoldiarylmethane
vx-770ivacaftor : An aromatic amide obtained by formal condensation of the carboxy group of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid with the amino group of 5-amino-2,4-di-tert-butylphenol. Used for the treatment of cystic fibrosis.

ivacaftor: a CFTR potentiator; structure in first source
aromatic amide;
monocarboxylic acid amide;
phenols;
quinolone
CFTR potentiator;
orphan drug
lumacaftorlumacaftor : An aromatic amide obtained by formal condensation of the carboxy group of 1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropane-1-carboxylic acid with the aromatic amino group of 3-(6-amino-3-methylpyridin-2-yl)benzoic acid. Used for the treatment of cystic fibrosis.

lumacaftor: a corrector of CF transmembrane conductance regulator (CTFR); structure in first source
aromatic amide;
benzodioxoles;
benzoic acids;
cyclopropanes;
organofluorine compound;
pyridines
CFTR potentiator;
orphan drug
nothofaginnothofagin: a dihydrochalcone
canagliflozincanagliflozin hydrate : A hydrate that is the hemihydrate form of canagliflozin. Used for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2.C-glycosyl compound;
organofluorine compound;
thiophenes
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
pf 04971729ertugliflozin: structure in first sourcediarylmethane
deberza2-benzofurans